| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |